Nuvectra Corporation announced preliminary unaudited consolidated revenue guidance for the fourth quarter and full year ended December 31, 2017. For the fourth quarter, the company expects revenue to be in the range of $11.5 to $12.0 million, compared to $4.2 million in the fourth quarter of 2016. Preliminary unaudited Algovita revenue for the fourth quarter of 2017 is expected to be in the range of $10.0 to $10.5 million, compared to $2.0 million in the fourth quarter of 2016. For the full year of 2017, the company’s revenue is expected to be in the range of $31.5 million to $32.0 million, compared to $12.5 million for full year 2016.